Click here and search for over 500 products and read the guarantees!      ¿Quieres español?

Site Map


To view our Credit Card Compliance Certificate Click the above Image.

 

$1.57 each  80 tabs
Free Shipping

Generic Viagra

Advertismewnts

$1.80 each 75 tabs
Free Shipping

Generic Cialis
$2.43 each 90 tabs
Free Shipping

Generic Levitra

Generic Zocor
Per pill to $0.87
Generic Propecia
Per pill  to $0.57
Generic Acomplia: As low as $1.66/pill

The above "Chat" is for www.4rx.com the leader in online pharmacies!
(Advertisement)

Subscribe to our 
Newsletter. Free!

 
Subscribe
Unsubscribe

Home
Sitemap
How to Order
Secure Order Form
Contact Us

Product Information
5-HTP
5-HTP Library
Acetylcholine
Acetyl-L-Carnitine
Alluna™
Alpha-Lipoic Acid
Amino Acids
Amoxicillin 
AndrosteDERM
Androstat
Apomorphine
Arginine
Books
Books on Menopause
Cialis - Generic
Citicoline
CoQ-10
DHA
DHEA
Dim (Diindolylmethane)
Ephedra Ban
Erectile Dysfunction Package
Erections
First Aid
Folic Acid
Gamma-Oryzanol
Generic Drugs
Ginko Biloba
Glutamine
hGH-PH Complex
Histidine
Hops
Horny Goat Weed
Human Sexuality
Hyaluronic Acid
Impotence
IP-6
LI 160 St. John's Wort
Levitra - Generic
MSM
Melatonin
Natural V
Niacin, Sustained Release
NorAndrosteDERM
Neuro-DHA
Passion Flower
Pregnenolone
Progesterone Cream 
Progesterone, Natural
Projuvine
Progesterone in Vitamin E Oil
Progesterone-Transdermal Spray
PRO hGH
PROhGH Sport For Women
Pro Sports Creme
Rejuvine
Resveratrol
Secretagogue-One
Sexual Dysfunction Pak-Women
Skin Fold Calipers
TransMist™-Progesterone Transdermal Spray
TriBuplex
Valerian Extract
Viagra - Generic
Vitamin B6
VitaminB12
Vitamin C, Time Released
Womens Libido tied to DHEA

General Information

5-HTP Update
About Pharmasan Labs
Aging: A Specific 
Alzheimers
Apomorphine  HGH
Body Temperature & Sleep
Biological Function
Aging
Alternative Medicine
Beta Blockers
Biological Clocks
Building Muscle Mass in the Aging
Compounding Pharmacy
Coronary Heart Disease
DHEA
Depression
Depression, Male
Diindolylmethane DIM
Dreaming
End-of-life
Ephedra Ban
Erectile Dysfunction 
Erections
Estrogen Dominance
Ginkgo Trees, order
Glossary
Growth Hormone Stimulators
Heart Attacks and Neuro DHA
Heart Clinic, The
Herbs & Botanicals
Herbs - The American Approach
Herbs - The German Approach
Homocysteine
Hormone Balance in the Menopausal Female
Hormone Replacement Therapy
Human Growth Hormone
Hormone Replacement Library - Women
Impotence
Insomnia
IP-6 Inositol Hexaphosphate
IP6 Gov Report
Lukemia & HGH
Library 5-HTP
Library - HRT
Light
Lupus & DHEA, From The FDA:
Mania
Menopause Therapy-News
Natural V Testosterone
Pain
Penis Enlargement - Facts and Fiction
Perimenopause
Pituitary Gland
Progesterone
Progesterone Deficiency
Progesterone-The Real story
ProHormones
Resveratrol
Sexual dysfunction-Women
Sexual Dysfunction-Men
Sirtuins
Sleep Clinic, The
Suicide
Telomerase
Temperature, Body & Sleep
Testosterone For Women
Testosterone & Men
Testosterone Dominance
Testosterone & Women
Testosterone, Maintaining Levels
Vitamin C, Time Released
Vitamins, Minerals & Amino Acids
Woman's Body, Image & Health
Womens Libido tied to DHEA

 

Simvastatin and other drugs in the "statin" class, muscle pain & muscle Loss

 

Safety Announcement
Additional Information for Patients 
Additional Information for Healthcare Professionals 
Data Summary 
Simvastatin Dose Limitations 

   

Safety Announcement

[3-19-2010] Based on review of data from a large clinical trial and data from other sources, the U.S. Food and Drug Administration (FDA) is informing the public about an increased risk of muscle injury in patients taking the highest approved dose of the cholesterol-lowering medication, Zocor* (simvastatin) 80 mg, compared to patients taking lower doses of simvastatin and possibly other drugs in the "statin" class.

The clinical trial data being reviewed is from the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) trial. The agency is also reviewing data from other clinical trials, observational studies, adverse event reports, and data on prescription use of simvastatin to better understand the relationship between high-dose simvastatin use and muscle injury (see Data Summary below).

The muscle injury, also called myopathy, is a known side effect with all statin medications. Patients with myopathy generally have muscle pain, tenderness or weakness, and an elevation of a muscle enzyme in the blood (creatine kinase). The higher the dose of statin used, the greater the risk of developing myopathy. The risk of myopathy is also increased when simvastatin, especially at the higher doses, is used with certain drugs (see Simvastatin Dose Limitations below).

The most serious form of myopathy is called rhabdomyolysis. It occurs when a protein (myoglobin) is released as muscle fibers break down. Myoglobin can damage the kidneys. Patients with rhabdomyolysis may have dark or red urine and fatigue, in addition to their muscle symptoms. Damage to the kidneys from rhabdomyolysis can be so severe that patients may develop kidney failure, which can be fatal.

Known risk factors for developing rhabdomyolysis include age (> 65 years), low thyroid hormone levels (hypothyroidism), and poor kidney function. Myopathy and rhabdomyolysis are listed as possible side effects in the simvastatin and other statin drug labels.

| Back to Top |

Healthcare professionals should:
Understand that rhabdomyolysis is a rare adverse event reported with all statins.
Be aware of the potential increased risk of muscle injury with the 80 mg dose of simvastatin compared to lower doses of simvastatin and possibly other statin drugs.
Follow the recommendations in the simvastatin label regarding drugs that may increase the risk for muscle injury when used with simvastatin (see Simvastatin Dose Limitations below). 

| Back to Top |

Patients should:
Not stop taking simvastatin unless told to by their healthcare professional.
Talk to their healthcare professional about any questions they have about the use of simvastatin.
Call their healthcare professional if they experience any of the following: muscle pain, tenderness or weakness, urine that is dark or red-colored, or unexplained tiredness.

This communication is in keeping with FDA's commitment to inform the public about its ongoing safety review of drugs. The agency will update the public as soon as this review is complete.

*Simvastatin is sold as a single-ingredient generic medication and as the brand-name, Zocor. It is also sold in combination with ezetimibe as Vytorin; and niacin as Simcor.

| Back to Top |

Additional Information for Patients

Patients currently using 80 mg simvastatin should:

Know that rhabdomyolysis is a rare side effect reported with all statin medications.
Not stop taking simvastatin unless told to by their healthcare professional.
Review their medical history and current medications with their healthcare professional to determine if they should continue using simvastatin.
Talk to their healthcare professional about any questions or concerns they have about simvastatin.
Call their healthcare professional if they have muscle pain, tenderness or weakness, dark or red colored urine, or unexplained tiredness.
Report any side effects with simvastatin to FDA's MedWatch program using the information at the bottom of the page in the "Contact Us" box.

| Back to Top |

Additional Information for Healthcare Professionals

FDA recommends that healthcare professionals should:

Understand that rhabdomyolysis is a rare adverse event reported with all statins.
Be aware of the potential increased risk of muscle injury with the 80 mg dose of simvastatin compared to lower doses of simvastatin and possibly other statin drugs.
Review patients' medical history and medications to determine if simvastatin is clinically appropriate.
Discuss with patients the benefits and risks, including the risk of myopathy and rhabdomyolysis, of simvastatin therapy.
Be aware of potential drug-drug interactions with simvastatin.
Report any adverse events associated with the use of simvastatin to FDA's MedWatch program using the information in the "Contact Us" box at the bottom of the page.

| Back to Top |

Data Summary

FDA's review of the SEARCH trial is part of the agency's continuing effort to evaluate the risk of muscle injury with simvastatin; this review includes evaluating data from clinical trials, observational studies, and adverse event reports, as well as data on prescription use of simvastatin.

The SEARCH trial evaluated over 6.7 years the number of major cardiovascular events (heart attack, revascularization, and cardiovascular death) in 6031 patients taking 80 mg of simvastatin compared to 6033 patients taking 20 mg of simvastatin. All patients in the study had previously had a heart attack.

Preliminary SEARCH trial results revealed that more patients in the simvastatin 80 mg group developed myopathy compared to patients in the simvastatin 20 mg group (52 [0.9%] cases compared to 1 case [0.02%]). Further, FDA's preliminary analyses of the primary data suggest that 11 (0.2%) of the patients in the simvastatin 80 mg group developed rhabdomyolysis compared to no patients in the simvastatin 20 mg group.

In 2008, the agency alerted the public about an increased risk of developing rhabdomyolysis when doses greater than 20 mg of simvastatin are given with amiodarone. The agency also included information about this drug interaction in its Summer 2008 issue of the FDA Drug Safety Newsletter and in its November 2008 Patient Safety News broadcast.

In March 2010, FDA approved a labeling revision for simvastatin based on interim results from an ongoing clinical trial – the Heart Protection Study 2 (HPS2). The revised label states that patients of Chinese descent should not receive simvastatin 80 mg with cholesterol-modifying doses of niacin-containing products. Further, the revised label recommends caution when such patients are treated with simvastatin 40 mg or less in combination with cholesterol-modifying doses of niacin-containing products. The interim HPS2 results showed that the incidence of myopathy was higher in patients of Chinese descent (0.43%) compared with patients not of Chinese descent (0.03%) taking 40 mg simvastatin plus cholesterol-modifying doses (≥1 g/day) of a niacin-containing product. It is not known if the increased risk for myopathy observed in these patients applies to other patients of Asian descent.

Moreover, FDA has requested that the sponsor of simvastatin change the product labeling to instruct healthcare professionals to avoid prescribing simvastatin doses greater than 40 mg daily when patients are taking the medication diltiazem, due to an increased risk for myopathy.

A 2010 review of prescription drug use data conducted by FDA found that, despite dose limitations and drug-drug interaction precautions included in the simvastatin drug label, patients are continuing to be prescribed higher doses of simvastatin with other medications that are known to increase the risk for rhabdomyolysis (see Simvastatin Dose Limitations below).

It is important for healthcare professionals to consider the potential risks and known benefits of simvastatin compared to other cholesterol-lowering therapies when deciding to use simvastatin. Healthcare professionals should also carefully review patients' medications for potential drug-drug interactions before prescribing or dispensing simvastatin.

This communication is in keeping with FDA's commitment to inform the public about its ongoing safety review of drugs. The agency will update the public as soon as this review is complete.

| Back to Top |

Simvastatin Dose Limitations

These limitations apply to ALL patients taking simvastatin.

  Do not use simvastatin with these medications:

Itraconazole
Ketoconazole
Erythromycin
Clarithromycin
Telithromycin
HIV protease inhibitors
Nefazodone

  Do not use more than 10mg of simvastatin with these medications:

Gemfibrozil
Cyclosporine
Danazol

  Do not use more than 20mg of simvastatin with these medications:

Amiodarone
Verapamil

  Do not use more than 40mg of simvastatin with this medication:

Diltiazem
    

| Back to Top |

 

Contact The FDA

Report a Serious Problem

1-800-332-1088
1-800-FDA-0178 Fax

MedWatch Online

Regular Mail: Use postage-paid FDA Form 3500

Mail to: MedWatch 5600 Fishers Lane

Rockville, MD 20857

 

| Back to Top |

Advertismewnts

For 10% discount use:
"hormone10" 
4rX.com Pharmacy

$1.57 each  80 tabs
Free Shipping

Generic Viagra

$1.80 each 75 tabs
Free Shipping

Generic Cialis

$2.43 each 90 tabs
Free Shipping

Generic Levitra

$1.80 each 75 tabs
Free Shipping for the best

Generic Cialis

$1.80 each 75 tabs
Free Shipping for the best

Generic Cialis

www.4rx.com
Click here for
 Espanol

Advertismewnts

For 10% discount use:
"hormone10" 

Aclepsa.com

$1.56 each 70 tabs
Free Shipping

Generic Viagra

$1.72 each 90 pills
Free Shipping

Generic Cialis

$2.65 each 60 pills
Free Shipping

Generic Levitra

$1.72 each 90 pills
Free Shipping

Generic Cialis

$1.72 each 90 pills
Free Shipping

Generic Cialis

 

© 1998-2014 by The Hormone Shop, LLC.

Norman@thehormoneshop.com
This page was last updated on 08/19/11

This Site does not endorse any product advertised on it.

Please note that the sale of DHEA or Melatonin is not available, legally in Australia or any member nations of the
European Union (excluding the United Kingdom & Switzerland). Customers must  have a valid prescription in order to purchase
these products in Australia or any member nations of the European Union (excluding the United Kingdom & Switzerland)

Disclaimer: The Hormone Shop LLC assumes no liability, whether under a theory of contract, tort, negligence, product liability or otherwise. In no event shall The Hormone Shop LLC be liable for any direct or indirect, consequential, incidental, special, punitive or exemplary damages, or for any loss incurred due to results or comments that are reported or the use of collection materials that are supplied, or any prescriptions regardless of whether The Hormone Shop LLC knew or should have known of the possibility of such damages. Furthermore, in no event  shall The Hormone Shop LLC's total cumulative liability exceed The Hormone Shop LLC's net profit on any specific product, sample or  consultation giving rise to the liability.  The Hormone Shop LLC specifically assumes no liability incurred by any 3rd party associate and if you are reading this web site in a language other that English it has been machine translated by SYSTRAN who strives to achieve the highest possible accuracy, however no automated translation is perfect nor is it intended to replace human translators. Users should note that the quality of the source text significantly affects the translations and The Hormone Shop LLC assumes no liability for incorrect or misleading translations.  The questions and comments appearing in the "Discussion Group Forum" are strictly from unknown or unidentified sources and the reader/participant should be aware that credentials from any source are completely lacking and should be questioned.  The Hormone Shop LLC specifically assumes no liability for any comment or advice appearing in the "Discussion Forum".

These statements have not been evaluated by the Food & Drug
Administration. These products are not intended to diagnose, cure, treat or prevent
any disease. If pregnant or lactating, consult a physician before using.

Notice: This information on anti-aging products  is provided for educational and nutritional purposes. Any medical procedures, dietary changes or the use of dietary supplements discussed herein should only be undertaken on the advice of a qualified medical doctor. Although listed and sold as dietary supplements these are not innocuous, inert substances; rather they can and do affect vital systems within the human body and it is for this reason that you are urged to find a medical doctor who will work with you in monitoring and maintaining your well being.

These sites are the design work of Norman Rose who can be reached at norman@thehormoneshop.com 

http://thehormoneshop.com
http://www.drugsfromindia.net
http://www.ginkgo-inc.com
http://www.kc-real-estate.com
http://www.cybernetrealty.net
http://www.thehormoneshop.net 
http://www.thehormoneshop.org 
http://www.thehormoneshop.biz 
http://www.thehormoneshop.us 
http://www.thehormoneshop.net
http://www.comparegenerics.net 
http://www.indiagenerics.org 
http://www.genericsinspanish.com   
http://www.genericsince1998.com
 

http://www.cialisfromindia.com
http://www.levitrafromindia.com
http://www.viagrafromindia.com 
Pregnenolone
Products & Info
Progesterone
DHEA
Products & Info
Erectile Dysfunction
Sexual Dysfunction-Women
Horny Goat Weed
Estro Gentle
Prostate
Leukemia
HGH Stimulators
HGH
5-HTP Update
Home Frame
Laboratory
Secretagogues
Pregnenolone
Progesterone
Progesterone+E
5-HTP
5-HTP Library
5-HTP Update
Growth Hormones
Stimulators
Order Form
Book Store
Prostate Cancer
FTC Crack Down
hGH-PH Complex